Head and Neck Cancer Trial, Recruiting NCT06236464 Sponsor: National Cancer Institute, Naples Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06236464
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with squamous cell carcinoma (a type of cancer) affecting one of these areas: the anus, cervix (neck of the womb), vulva, or head and neck region — including early-stage or more advanced forms
  • You are being considered for surgery as part of your treatment
  • You are able to understand and willing to sign a consent form agreeing to take part

Who may not be able to join:

  • Your cancer has spread to other parts of the body (metastatic cancer)
  • You are currently receiving treatment for another type of cancer
  • You have a condition that weakens your immune system, whether you were born with it, developed it (such as HIV), received an organ transplant, or take medication that suppresses your immune system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maria Lina Tornesello, M.D., IRCCS I.N.T. "G. Pascale"

Phone: 08117770588

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Cancer Institute, Naples
Registry
ClinicalTrials.gov
Start date
25 September 2023
Est. completion
19 November 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Primary Endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov